SCHEMBL6713233

SCHEMBL6713233

O=C(Cc1ccc(Cl)cc1Cl)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.41
GALR3 O60755 1/20 0.39
NR2F2 P24468 1/20 0.39
PLCG2 P16885 1/20 0.39
NHERF1 O14745 2/20 0.37
PLA2G7 Q13093 1/20 0.36
PARP14 Q460N5 1/20 0.36
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
ROCK2 O75116 1/20 0.36
KDM4E B2RXH2 1/20 0.36
F11 P03951 1/20 0.35
RECQL P46063 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
POLB P06746 1/20 0.35
PTK2B Q14289 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713652 0.95 GRIK1 (0.45) GRIK1GALR3NR2F2PLCG2NHERF1
SCHEMBL6710278 0.94 PARP14 (0.43) GRIK1PLCG2NHERF1PLA2G7PARP14
SCHEMBL6709095 0.93 GRIK1 (0.37) GRIK1GALR3NR2F2PLCG2NHERF1
SCHEMBL6710159 0.91 GRIK1 (0.41) GRIK1PLCG2NHERF1PLA2G7LMNA
SCHEMBL6707627 0.91 KMT2A (0.46) GRIK1PLCG2NHERF1PLA2G7PARP14
SCHEMBL6713394 0.90 PARP14 (0.42) GRIK1PLCG2NHERF1PLA2G7PARP14
SCHEMBL6710031 0.90 NSD2 (0.41) GRIK1PLCG2NHERF1PLA2G7PARP14
SCHEMBL6709861 0.89 GRIK1 (0.41) GRIK1PLCG2NHERF1PARP14ALDH1A1
SCHEMBL6708770 0.89 GRIK1 (0.41) GRIK1PLCG2PLA2G7PARP14LMNA
SCHEMBL6711895 0.89 PARP14 (0.44) GRIK1PLCG2NHERF1PLA2G7PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885GALR3 4874/4885NR2F2 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.